LexDanaLexDanabeta
Inventor

Andrew Miller

Inventor
Oxford, GB

Overview

68→
Patents
1993–2016
Patent span
Chemistry
Primary field (CPC C)

Patents· 68 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes15%
C07CAcyclic or carbocyclic compounds12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
Y02ATechnologies for adaptation to climate change2%
C07KPeptides1%
F25BRefrigeration machines, plants or systems1%
F28FDetails of heat-exchange and heat-transfer apparatus, of general application1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
9,499,497'Compounds useful as inhibitors of indoleamine 2,3-dioxygenase'20169,193,722'Tri-cyclic pyrazolopyridine kinase inhibitors'20159,073,875'Compounds useful as inhibitors of indoleamine 2,3-dioxygenase'20159,067,932'Pyrazolopyridine kinase inhibitors'20158,895,740'Pyrazolopyrazine kinase inhibitors'20148,809,335'Pyrazolopyrimidine kinase inhibitors'20148,779,127'Processes for preparing substituted pyrimidines'20148,669,081'Compositions useful as inhibitors of protein kinases'20148,664,219'Aminopyrimidines useful as inhibitors of protein kinases'20148,637,511'Aminopyrimidines useful as kinase inhibitors'20148,569,337'Tri-cyclic pyrazolopyridine kinase inhibitors'20138,426,425'Aminopyrimidines useful as inhibitors of protein kinases'20138,372,850'Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases'20138,372,835'Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases'20138,367,697'Kinase inhibitors'20138,268,829'Substituted pyrimidines useful as protein kinase inhibitors'20128,173,635'Kinase inhibitors'20128,129,399'Aminopyrimidines useful as kinase inhibitors'20127,982,037'Pyrazole compounds useful as protein kinase inhibitors'20117,875,712'Caspase inhibitors and uses thereof'20117,863,282'Compositions useful as inhibitors of protein kinases'20117,807,659'Caspase inhibitors and uses thereof'20107,795,259'Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases'20107,767,672'Aminopyrimidines useful as kinase inhibitors'20107,625,913'Pyrazole compounds useful as protein kinase inhibitors'20097,557,106'Substituted pyrimidines useful as protein kinase inhibitors'20097,531,536'Pyrazole compounds useful as protein kinase inhibitors'20097,528,142'Aminopyrimidines useful as kinase inhibitors'20097,514,448'Azaindoles useful as inhibitors of rock and other protein kinases'20097,442,790'Caspase inhibitors and uses thereof'20087,351,702'Caspase inhibitors and uses thereof'20087,179,826'Compositions useful as inhibitors of protein kinases'20077,091,343'Compositions useful as inhibitors of protein kinases'20066,846,928'Compositions useful as inhibitors of protein kinases'20056,664,247'Pyrazole compounds useful as protein kinase inhibitors'20036,653,300'Pyrazole compounds useful as protein kinase inhibitors'20036,358,987'Metalloproteinase inhibitors'20026,271,262'Metalloproteinase inhibitors'20016,124,329'Metalloproteinase inhibitors'20006,124,333'Metalloproteinase inhibitors'20006,124,332'Metalloproteinase inhibitors'20006,103,739'Metalloproteinase inhibitors'20006,028,110'Succinyl hydroxamic acid, N-formyl-N-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors'20006,022,898'Metalloproteinase inhibitors'20006,022,873'Metalloproteinase inhibitors'20006,017,889'Metalloproteinase inhibitors'20005,962,529'Metalloproteinase inhibitors'19995,917,090'Matrix metalloproteinase inhibitors'19995,908,851'Derivatives of succinamide and their use as metalloproteinase inhibitor'19995,902,791'Metalloproteinase inhibitors'19995,866,717'Metalloproteinase inhibitors'19995,861,436'Hydroxamic acid derivatives as metalloproteinase inhibitors'19995,859,253'Metalloproteinase inhibitors'19995,840,939'Derivatives of succinamide and their use as metalloproteinase inhibitors'19985,763,621'Metalloproteinase inhibitors'19985,753,671'Imidazopyridine derivatives as dual histamine (H.sub.1) and platelet activating factor (PAF) antagonists'19985,747,514'Metalloproteinase inhibitors'19985,741,794'Heterocyclic sulfonamide derivatives as antagonists of PAF and angiotensin II'19985,637,595'Cyclic ether acetal PAF antagonists'19975,563,151'Amino acid derivatives as paf-receptor antagonists'19965,516,783'4-(1H-2-methylimidazo[4,5-c]pyridinylmethyl)phenylsulphonamide derivatives as antagonist of PAF'19965,451,676'Biphenyl ether heterobicyclic platelet activating factor antagonists'19955,446,032'Imidazo (4,5-C) pyridine derivatives as PAF antagonists'19955,276,153'Production of certain imidazopyridinyl-methyl-benzene sulfonamides'19945,274,094'Production of heterobicyclic containing benzene sulfonamides'19935,200,412'Heterobicyclic containing benzene sulfonamides which are platelet activating factor antagonists'19935,180,723'Certain sulfonamide heterobicyclic platelet activating factor antagonists'19935,180,724'Carboxamide amino acid heterobicyclic PAF antagonists'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2002Based in Oxford, GB· patent location history
1993–2010Based in Oxfordshire, GB· patent location history
1995–2002Patents assigned to BRITISH BIOTECH PHARM (26)· patent assignee history
2003–2016Patents assigned to VERTEX PHARMA (36)· patent assignee history
2003–2016Based in Didcot, GB· patent location history
2005–2015Based in Upton, GB· patent location history
2009–2015Based in Abingdon, GB· patent location history
2012–2015Patents assigned to MILLER ANDREW (13)· patent assignee history
2012–2015Patents assigned to JIMENEZ JUAN-MIGUEL (8)· patent assignee history
2012–2015Patents assigned to FRAYSSE DAMIEN (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VERTEX PHARMA362003–2016
BRITISH BIOTECH PHARM261995–2002
MILLER ANDREWself132012–2015
JIMENEZ JUAN-MIGUEL82012–2015
FRAYSSE DAMIEN72012–2015
Locations
LocationPatentsSpan
Oxford, GB211993–2002
Upton, GB192005–2015
Abingdon, GB82009–2015
Didcot, GB72003–2016
Oxfordshire, GB41993–2010